About Zinc finger protein 235
Zinc finger protein 235 (ZNF235) is a protein
from Homo sapiens identified by UniProt accession
Q14590, 738 residues long.
MolForge cross-references it against 0 known binders and
3 disease associations.
Target properties
| Protein name | Zinc finger protein 235 |
| UniProt accession | Q14590 |
| Gene | ZNF235 |
| Organism | Homo sapiens |
| Length | 738 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (3)
Diseases linked to this target (Open Targets).
- C-reactive protein measurement · score 0.12
- leukocyte count · score 0.02
- Zinc deficiency · score 0.00
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q14590-F1 | alphafold | PREDICTED | 67.48 | — |
Amino-acid sequence (738 residues)
MTKFQEAVTF KDVAVAFTEE ELGLLDSAQR KLYRDVMLEN FRNLVSVGHQ SFKPDMISQL EREEKLWMKE LQTQRGKHSG DRNQNEMATL HKAGLRCFSL GELSCWQIKR HIASKLARSQ DSMINIEGKS SQFPKHHDSP CQVGAGESIQ ASVDDNCLVN HIGDHSSIIE NQEFPTGKVP NSWSKIYLNE TQNYQRSCKQ TQMKNKLCIF APYVDIFSCI SHHHDDNIVH KRDKVHSNSD CGKDTLKVSP LTQRSIHTGQ KTYQGNECEE AFNDSSSLEL HKQVHLGKKS PACSTHEKDT SYSSGIPVQQ SVRTGKKRYW CHECGKGFSQ SSNLQTHQRV HTGEKPYTCH ECGKSFNQSS HLYAHLPIHT GEKPYRCDSC GKGFSRSTDL NIHCRVHTGE KPYKCEVCGK GFTQRSHLQA HERIHTGEKP YKCGDCGKRF SCSSNLHTHQ RVHTEEKPYK CDECGKCFSL SFNLHSHQRV HTGEKPYKCE ECGKGFSSAS SFQSHQRVHT GEKPFRCNVC GKGFSQSSYF QAHQRVHTGE KPYKCEVCGK RFNWSLNLHN HQRVHTGEKP YKCEECGKGF SQASNLQAHQ SVHTGEKPFK CDACQKRFSQ ASHLQAHQRV HTGEKPYKCD TCGKAFSQRS NLQVHQIIHT GEKPFKCEEC GKEFSWSAGL SAHQRVHTGE KPYTCQQCGK GFSQASHFHT HQRVHTGERP YICDVCCKGF SQRSHLIYHQ RVHTGGNL
Explore Zinc finger protein 235 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets